Please login to the form below

Not currently logged in
Email:
Password:

MRC

This page shows the latest MRC news and features for those working in and with pharma, biotech and healthcare.

LifeArc takes $30m equity stake in Kymab, gains access to antibody tech

LifeArc takes $30m equity stake in Kymab, gains access to antibody tech

This is thanks to LifeArc’s work (then known as MRC Technology) in humanising the mouse antibody on which Keytruda was based – thus the new Kymab collaboration is building on this

Latest news

More from news
Approximately 12 fully matching, plus 38 partially matching documents found.

Latest Intelligence

  • AstraZeneca: building a new ‘open innovation’ pharma company AstraZeneca: building a new ‘open innovation’ pharma company

    MRC scientists are welcome to work in the building and our oncology staff are working in the CRUK Institute.

  • 30 Women Leaders in UK Healthcare (part 3) 30 Women Leaders in UK Healthcare (part 3)

    26. Professor Janet Darbyshire, Emeritus Professor of Epidemiology, University College London, Honorary Senior Scientist, MRC Clinical Trials Unit. ... She established the MRC Clinical Trials Unit (CTU) at UCL as an internationally recognised centre of

  • 30 Women Leaders in UK Healthcare (part 2) 30 Women Leaders in UK Healthcare (part 2)

    20. Prof Rebecca Fitzgerald, MRC Cancer Unit, University of Cambridge, and Honorary Consultant in Gastroenterology, Cambridge University NHS Hospitals Foundation Trust.

  • Pharma deals during July 2014 Pharma deals during July 2014

    As part of the collaborative spirit, the UK's Medical Research Council (MRC) announced this month that it has entered into an arrangement under which seven leading pharma companies (AZ, GSK, ... J&J, Lilly, Pfizer, Takeda and UCB) have agreed to make

  • Pharma deals during March 2014 Pharma deals during March 2014

    Under the five-year agreement, scientists from the MRC will work closely with AZ's scientists to identify drug targets and screen promising candidates. ... MRC scientists will have access to AZ's vast compound library and will use high-throughput

More from intelligence
Approximately 0 fully matching, plus 5 partially matching documents found.

Latest appointments

  • EM Imaging appoints new chairman EM Imaging appoints new chairman

    Jeans also chairs the board of UK Biocentre, and has sat on advisory panels for the MRC, EPSRC, NIHR and the Wellcome Trust. .

  • MRC Technology appoints director of technology transfer MRC Technology appoints director of technology transfer

    Andrew Farquharson will join the firm from September 1. MRC Technology has named Andrew Farquharson as director of technology transfer, effective from September 1. ... Dr Dave Tapolczay, CEO at MRC Technology, added: “Andrew's extensive experience will

  • MRC Technology names finance director MRC Technology names finance director

    Andrew Mercieca took up the role on April 1. Independent life science medical research charity MRC Technology has named Andrew Mercieca as its finance director. ... Dave Tapolczay, CEO at MRC Technology, added: “Andrew has been a great asset to the

  • Medical Research Council selects Royal Mail’s Donald Brydon as new chair

    The UK's Medical Research Council (MRC) has appointed  Donald Brydon from the Royal Mail Group as its new chair. ... He will take over from John Chisholm in October at the MRC, a publicly-funded organisation focused on healthcare research.

More from appointments
Approximately 2 fully matching, plus 2 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
W2O Group

W2O Group is an integrated marketing agency with expertise in brand and digital strategy, creative development and communications services. We...

Latest intelligence

Report: Customer experience, shaping digital healthcare
In this issue of ‘Perspective’ we speak with industry experts to learn about the world of digital healthcare, and how pharma is beginning to utilise these modern technologies to enhance...
Biomarker
Encouraging signs in biomarker R&D
The cancer immunotherapy firms ramping-up biomarker R&D...
Programmatic methodology and why you should be using it
What is it? How does it work? Why is everyone talking about it? By Richard Webb - Associate Director...

Infographics